About HCAH
HCAH is a company based in Noida (India) founded in 2012 by Gaurav Burman and Vivek Srivastava. HCAH has raised $64.45 million across 5 funding rounds from investors including Mahindra, Quadria Capital and ImpactAssets. HCAH has completed 6 acquisitions, including Health Impetus, Medwell and Medwell Ventures. HCAH offers products and services including ICU at Home, Physiotherapy, Medical Equipment, Nursing Attendant, and Stroke Care. HCAH operates in a competitive market with competitors including Portea, Zoctr, Bharath Home Medicare, Click2Clinic and Care4Parents, among others.
- Headquarter Noida, India
- Founders Gaurav Burman, Vivek Srivastava
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$64.45 M (USD)
in 5 rounds
-
Latest Funding Round
$36.74 K (USD), Series B
May 18, 2024
-
Investors
Mahindra
& 21 more
-
Employee Count
Not available
-
Investments & Acquisitions
Health Impetus
& 5 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of HCAH
HCAH offers a comprehensive portfolio of products and services, including ICU at Home, Physiotherapy, Medical Equipment, Nursing Attendant, and Stroke Care.
Delivers intensive care and monitoring services at patient's residence
Provides physical therapy for strength and mobility recovery
Offers rental and use of branded medical devices for home care
Supplies trained attendants for daily patient assistance and monitoring
Focuses on restoring functions post-stroke through tailored rehabilitation
People of HCAH
Unlock access to complete
Product Management Team
2 people
SEO Team
1 people
Strategy Team
1 people
Key Team
1 people
Bdm Team
1 people
Unlock access to complete
Funding Insights of HCAH
HCAH has successfully raised a total of $64.45M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $36.74 thousand completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in HCAH
HCAH has secured backing from 22 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include Mahindra, Quadria Capital and ImpactAssets.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investment and global platform support for startups.
|
Locked | Locked | Locked | |
|
Seed-stage investments are targeted by Jacesa Investments venture capital firm.
|
Locked | Locked | Locked | |
|
Venture capital is provided to tech startups by the fund.
|
Locked | Locked | Locked |
Investor details for HCAH
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by HCAH
HCAH has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include Health Impetus, Medwell and Medwell Ventures.
Investment portfolio details for HCAH
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of home health care services
|
Locked | Locked | 2016 | Locked | |
|
Medical aids and devices for seniors are sold online.
|
Locked | Locked | 2016 | Locked | |
|
Home healthcare services are provided to chronic disease patients.
|
Locked | Locked | 2014 | Locked |
Complete acquisition details for HCAH
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - HCAH
Detailed financials for HCAH
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Hcah Comparisons
Peer comparison for HCAH
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of HCAH
HCAH operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Portea, Zoctr, Bharath Home Medicare, Click2Clinic and Care4Parents, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of at-home healthcare services including nursing, physiotherapy, and medical equipment
|
|
| Locked | Locked | Locked |
Online platform for booking appointment
|
|
| Locked | Locked | Locked |
Home healthcare service provider
|
|
| Locked | Locked | Locked |
Healthcare services are aggregated via an online booking platform.
|
|
| Locked | Locked | Locked |
Provider of health care assistance, analysis, and solutions for health records for the elderly
|
Detailed competitors of HCAH
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Hcah
Complete news archive for HCAH
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HCAH
HCAH was founded in 2012 and raised its 1st funding round 5 years after it was founded.
HCAH is headquartered in Noida, India. It is registered at Noida, Uttar Pradesh, India.
Vivek Srivastava is the current CEO of HCAH. They have also founded this company.
HCAH is a funded company, having raised a total of $64.45M across 5 funding rounds to date.
Founded in 2012 and headquartered in Noida, India, HCAH operates in the home healthcare sector. Services are provided by trained professionals, including nurses, physiotherapists, phlebotomists, pharmacists, and delivery drivers. In-home nursing care, post-operative support, elderly assistance, and physiotherapy treatments are offered to clients across the region, ensuring accessible medical attention without the need for hospital visits.
HCAH's top competitors include Portea, Bharath Home Medicare and HDU Healthcare.
HCAH offers ICU at Home, Physiotherapy, Medical Equipment, Nursing Attendant, and Stroke Care.
HCAH has made 6 acquisitions, including Health Impetus, Medwell, and Medwell Ventures.
HCAH has 22 investors. Key investors include Mahindra, Quadria Capital, ImpactAssets, Eight Roads Ventures, and Cytespace Research.
The valuation of HCAH is $75.58M as of May 2024.